The indication has been expanded to include use in newborns and allows patients and caregivers to apply the treatment at home.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dystrophic-epidermolysis-bullosa-fda-approves-labeling-2025a1000oip?src=rss
Author :
Publish date : 2025-09-16 18:49:00
Copyright for syndicated content belongs to the linked Source.
